7Jan2020We’ve Been Neglecting Common Diseases. We Need to Reverse this Trend/Alex Harding/0/All, Politics, Venture Capital07 Jan 2020Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.